Lopadine DS 0.2% is an ophthalmic solution designed for the treatment of ocular itching associated with allergic conjunctivitis. It is a non-steroidal antihistamine eye drop that offers effective relief from eye allergy symptoms such as itching, redness, and irritation.
Lopadine DS 0.2% is particularly convenient for once-daily dosing, making it suitable for patients who prefer simpler treatment regimens.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Ophthalmic Non-Steroid Drugs
Olopatadine, the active ingredient in Lopadine DS 0.2%, works through:
H1 Histamine Receptor Antagonism: Blocks histamine-mediated allergic reactions in the conjunctiva.
Mast Cell Stabilization: Prevents the release of histamine and other inflammatory mediators from mast cells, reducing allergic response.
Olopatadine is highly selective for H1 receptors and does not interfere with alpha-adrenergic, dopamine, or muscarinic receptors, which reduces systemic side effects. After ocular application, systemic absorption is minimal.
Lopadine DS 0.2% is indicated for:
Relief of ocular itching associated with allergic conjunctivitis
Treatment of seasonal and perennial eye allergies
0.2% Sterile Eye Drops: One drop in the affected eye once daily
Other strengths (for context):
0.1%: One drop twice daily
0.7%: One drop once daily
Special Instructions:
Remove soft contact lenses before use.
Wait at least 10 minutes after instillation before reinserting contact lenses.
Additive CNS depression may occur if used with other CNS depressants.
Known hypersensitivity to Olopatadine or any component of the ophthalmic solution.
Common and mild side effects include:
Headache (~7% incidence)
Blurred vision
Burning or stinging sensation
Dry eyes, pruritus, hyperemia
Less common: asthenia, nausea, pharyngitis, sinusitis, lid edema, taste perversion
Should be used in pregnancy only if clearly needed.
Caution in nursing mothers; systemic absorption is minimal but caution is advised.
Not indicated for contact lens-related irritation.
Avoid contaminating the dropper tip.
Do not use beyond 30 days after first opening.
Symptoms: Drowsiness in adults; initial agitation followed by drowsiness in children.
Management: Symptomatic and supportive treatment.
Store below 30°C in a cool, dry place, protected from light.
Keep out of reach of children.
Geriatric Use: No significant differences in safety or effectiveness compared to younger adults.
Login Or Registerto submit your questions to seller
No none asked to seller yet